ArticleFrontiers in oncology2022

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.